Please provide your email address to receive an email when new articles are posted on . Twelve-month data from a large U.S. registry study confirmed the clinical utility and high negative predicative ...

Your skin is your largest organ, but it doesn’t get the attention it deserves—especially when it comes to skin checks for cancer. That should change, says Dr. Susan Massick, associate professor of ...

As part of this partnership, Affidea has implemented Skin Analytics’ DERM, an AI medical device software for the automated analysis of skin lesions. The initial implementation of DERM began in Romania ...

DERM is an artificial intelligence (AI)-based skin lesion analysis technology intended for use in the screening, triage and assessment of suspected skin cancer lesions in people aged 18 or over. DERM ...

In January, after the DermaSensor became the first artificial intelligence (AI)-enabled device cleared by the US Food and Drug Administration (FDA) to evaluate lesions suggestive of skin cancer, the ...

LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, announced today that ...

Oncopatch represents a meaningful addition to the treatment landscape for skin cancer…particularly in situations where ...

What is actinic keratosis? An actinic keratosis is a precancerous skin lesion. These lesions often appear as rough spots on the skin and are caused by sun exposure or indoor tanning. Untreated, they ...

FARGO, ND, UNITED STATES, February 24, 2026 /EINPresswire.com/ — Fargo Dermatology is thrilled to announce the addition of the GentleMax Pro Plus ® to their suite of advanced aesthetic treatments.

The diagnostics advisory committee considered evidence on Deep Ensemble for Recognition of Malignancy (DERM) to assess and triage skin lesions referred to the urgent suspected skin cancer pathway from ...